Versiti Acquired Pearl Pathways to Expand Clinical Trial Services Capabilities


Versiti has acquired Pearl Pathways to strengthen their existing IRB foothold and ability to offer broader regulatory support for clinical trials.


Recent shifts in healthcare highlight the crucial role of Institutional Review Boards (IRBs) and regulatory affairs consulting. The escalating complexity of research studies, coupled with emerging ethical challenges from technologies like big data analytics and precision medicine, underscores the imperative need for robust ethical oversight. IRB review becomes essential to safeguard participant rights and privacy as research expands into these realms. The emphasis on patient-centered care elevates IRBs’ role in aligning research with patient preferences. Simultaneously, regulatory affairs consulting is vital for navigating evolving regulations and ensuring compliance. Global research collaborations and the involvement of vulnerable populations accentuate the essential function of IRBs and regulatory affairs consulting in upholding ethical standards across diverse settings, protecting the rights and well-being of research participants.

Based in Indianapolis, Pearl Pathways is a comprehensive life science consulting firm, specializing in regulatory affairs, quality compliance, and niche CRO services. With an independent AHRPP-accredited IRB, they cover all facets of human research. They assist biopharmaceutical, medical device, and diagnostic entities, along with life science service providers, addressing their clinical, regulatory, and quality compliance requirements. Pearl’s noteworthy IRB capabilities and regulatory expertise positioned it perfectly to enhance Versiti’s current IRB and clinical trial service offerings.

Crosstree’s Role

Crosstree’s granular pharma services expertise helped Versiti identify Pear Pathways as the ideal acquisition target to expand and bolster its service offering through:

  • Developing and articulating a strong value proposition which connected Versiti’s capabilities with market trends to weave a compelling narrative for potential buyers
  • Introducing and nurturing relationship between Versiti and Pearl Pathways ensure a smooth partnership


Pharma Services

Micro Segment

Drug Development


Strategy Advisory and Origination Services

Deal Tags

Pharma Lab Services
Clinical Trials
Pharma Development
Pharma Consulting